Three-year follow-up of serial nerve conduction among lead-exposed workers

Nerve excitability test and lead toxicity: a case-control study

BACKGROUND

Although conventional electrophysiological parameters have been proposed as clinical indicators for monitoring lead neuropathies, their correlations with blood lead level are weak. In this study, we investigated the applicability of nerve excitability tests (NETs) to evaluate lead intoxication.

METHODS

Fourteen workers who were exposed to lead with an elevated blood level ranging from 17.8 to 64.9 µg/dL and 20 healthy controls with similar ages and body heights were enrolled. Both workers and controls underwent nerve conduction studies (NCSs), motor evoked potentials (MEPs) with transcranial magnetic stimulation (TMS), and NETs.

RESULTS

NCSs showed prolonged distal latencies and decreased motor nerve conduction velocity of median nerves in the workers but without significant correlation to blood lead level (BLL). Significantly prolonged MEP latency was observed in the workers (+ 6 ms). NETs demonstrated hyperpolarized resting membrane potentials in stimulus-response curves and changes in the property of potassium channels under a hyperpolarized current in threshold electrotonus, implying that lead hyperpolarized nerves by interfering with potassium channels. NETs also showed a better correlation with BLL than conventional electrophysiological parameters.

CONCLUSIONS

Axonal hyperpolarization and central conduction delay are more apparently reflecting elevated BLL than NCS. NET may have the potential for early detection of lead neuropathy.

Public and occupational health risks related to lead exposure updated according to present-day blood lead levels

Lead is an environmental hazard that should be addressed worldwide. Over time, human lead exposure in the western world has decreased drastically to levels comparable to those among humans living in the preindustrial era, who were mainly exposed to natural sources of lead. To re-evaluate the potential health risks associated with present-day lead exposure, a two-pronged approach was applied. First, recently published population metrics describing the adverse health effects associated with lead exposure at the population level were critically assessed. Next, the key results of the Study for Promotion of Health in Recycling Lead (SPHERL; NCT02243904) were summarized and put in perspective with those of the published population metrics. To our knowledge, SPHERL is the first prospective study that accounted for interindividual variability between people with respect to their vulnerability to the toxic effects of lead exposure by assessing the participants' health status before and after occupational lead exposure. The overall conclusion of this comprehensive review is that mainstream ideas about the public and occupational health risks related to lead exposure urgently need to be updated because a large portion of the available literature became obsolete given the sharp decrease in exposure levels over the past 40 years.

Two-Year Responses of Heart Rate and Heart Rate Variability to First Occupational Lead Exposure

[Figure: see text].

Impact of occupational lead exposure on nerve conduction study data

INTRODUCTION

To investigate nerve conduction data of lead exposed workers.

METHODS

A total of 287 subjects, consisting of 197 lead exposed workers and 90 healthy controls were included. Nerve conduction study of motor (median, ulnar, peroneal and tibial) and sensory (median, ulnar and sural) nerves were performed. The data were analyzed as two and three groups.

RESULTS

The median blood lead level was 40.90 µg/dl. Median sensory, ulnar motor, and ulnar sensory conduction velocity were lower; distal latency of median motor, median sensory and sural sensory were longer than the controls (p < 0.05). There was no difference between the groups in terms of amplitudes.

DISCUSSION

This study was indicated the neurotoxic effect of lead exposure may occur in the peripheral nerves, while the mean blood lead level is 40 µg/dl.

Review: Lead exposure in battery manufacturing and recycling in developing countries and among children in nearby communities

The battery industry is the largest consumer of lead, using an estimated 80% of the global lead production. The industry is also rapidly expanding in emerging market countries. A review of published literature on exposures from lead-acid battery manufacturing and recycling plants in developing countries was conducted. The review included studies from 37 countries published from 1993 to 2010 and excluded facilities in developed countries, such as the United States and those in Western Europe, except for providing comparisons to reported findings. The average worker blood lead level (BLL) in developing countries was 47 μg/dL in battery manufacturing plants and 64 μg/dL in recycling facilities. Airborne lead concentrations reported in battery plants in developing countries averaged 367 μg/m3, which is 7-fold greater than the U.S. Occupational Safety and Health Administration's 50 μg/m3 permissible exposure limit. The geometric mean BLL of children residing near battery plants in developing countries was 19 μg/dL, which is about 13-fold greater than the levels observed among children in the United States. The blood lead and airborne lead exposure concentrations for battery workers were substantially higher in developing countries than in the United States. This disparity may worsen due to rapid growth in lead-acid battery manufacturing and recycling operations worldwide. Given the lack of regulatory and enforcement capacity in most developing countries, third-party certification programs may be the only viable option to improve conditions.

Effect of lead exposure and ergonomic stressors on peripheral nerve function

In this study we investigated the effect of recent and chronic lead exposure, and its interaction with ergonomic stressors, on peripheral nerve function. In a cross-sectional design, we used retrospective exposure data on 74 primary lead smelter workers. We measured blood and bone lead levels and, from historical records, calculated lead dose metrics reflecting cumulative lead exposure: working-lifetime integrated blood lead (IBL) and working-lifetime weighted-average blood lead (TWA). We additionally created five metrics related to IBL that cumulated exposure only above increasing blood lead levels ranging from 20 to 60 microg/dL (IBL20-IBL60). Current perception threshold (CPT) assessed large myelinated (CPT2000), small myelinated (CPT250), and unmyelinated (CPT5) sensory nerve fibers. Using multiple linear regression, we modeled CPT on the different measures of lead dose after adjusting for relevant covariates. CPT had a curvilinear relationship with TWA, with a minimum at a TWA of 28 microg/dL. Both TWA and IBL accounted for a significant percentage of the variance of CPT2000 (DeltaR2 = 8.7% and 3.9%, respectively). As the criterion blood lead level increased from IBL20 through IBL60, so did the percentage of CPT2000 variance explained, with DeltaR2 ranging from 5.8% (p < 0.03) for IBL20 to 23.3% (p < 0.00) for IBL60. IBL60 also significantly contributed to the explanation of variance of CPT250 and significantly interacted with ergonomic stressors. Measures of chronic blood lead exposure are associated with impairment of large and small myelinated sensory nerve fibers. This effect is enhanced at the highest doses by ergonomic stressors.

Neurotoxicity Assessment of Chemicals on Exposed Workers — A Review of Neurobehavioral and Neurophysilogical Tests

With the wide utilization of neurotoxic substances, more and more people are exposed to them occupationally or environmentally. Neurotoxicity has been defined as any adverse effect on the structure or function of the central and /or peripheral nervous system by biological, chemical and physical agent. Neurotoxic effect may be permanent or reversible, caused by neuropharmacological or neurodegenerative properties of a neurotoxicant. The nervous system is very sensitive and fragile to chemicals. The early adverse effects should be detected as early as possible because they are reversible, functional and chemical, not structural. A multidisciplinary approach is necessary to assess neurotoxicity because of the complexity and diverse functions of the nervous system. Many of the relevant effects can be measured directly by neurochemical, neurophysiological, and neuropathological techniques, whereas, others must be inferred from observed behavior and psychic performance. Neurotoxicity in humans is most commonly measured by relatively noninvasive neurophysiological and neurobehavioral methods that assess cognitive, affective, sensory, and motor function. The biomarker assay can be complement. In general, due to the speciality and difficult accessibility, the biomarkers that manifest the neurotoxicity of chemicals in nervous system are difficult to obtain, but a number of biochemical and molecular parameters similar to those involved as toxicity targets in the nervous system are also present in more easily accessible tissues, such as cerebrospinal fluid (CSF), blood, plasma and peripheral blood cells. These tissues can be surrogate indicators. With the multidisciplinary approach, the neurotoxicity of chemicals can be assessed or screened sensitively and practically.